Review
Published on 08 Mar 2024
Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2024.1347708
- 1,513 views
Type at least 3 characters
107 articles
Articles
Case Report
Published on 06 Mar 2024
Case report: Childhood erythrocytosis due to hypermanganesemia caused by homozygous SLC30A10 mutation
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1331485
- 667 views
- 1 citation
Case Report
Published on 06 Mar 2024
Case report: A patient with ALK-positive large B-cell lymphoma benefited from myeloma-like treatment combined with the ALK inhibitor lorlatinib
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1334577
- 712 views
Review
Published on 01 Mar 2024
Exploring the intricate cross-talk between clonal expansion and the bone marrow niche
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1334807
- 1,305 views
- 1 citation
Review
Published on 19 Feb 2024
Hypersialylation and multiple myeloma
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1360149
- 1,616 views
Review
Published on 15 Feb 2024
Research and clinical updates on IRAK4 and its roles in inflammation and malignancy: themes and highlights from the 1st symposium on IRAK4 in cancer
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1339870
- 3,161 views
- 4 citations
Original Research
Published on 05 Feb 2024
Predicting factors of survival rates among alpha- and beta-thalassemia patients: a retrospective 10-year data analysis
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1339026
- 2,543 views
Review
Published on 02 Feb 2024
How artificial intelligence revolutionizes the world of multiple myeloma
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1331109
- 2,335 views
- 3 citations
Brief Research Report
Published on 25 Jan 2024
Concanavalin A staining: a potential biomarker to predict cytarabine sensitivity in acute myeloid leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2023.1302328
- 1,020 views
- 1 citation
Review
Published on 25 Jan 2024
De novo drug design through artificial intelligence: an introduction
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1305741
- 4,833 views
- 1 citation
Original Research
Published on 19 Jan 2024
Generation, characterization, and use of EKLF(Klf1)/CRE knock-in mice for cell-restricted analyses
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2023.1292589
- 785 views
Mini Review
Published on 11 Jan 2024
Mini review of metabolism in leukaemia: from complexity to the clinic
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2023.1353994
- 681 views
Case Report
Published on 09 Jan 2024
Persistent hypersplenism following successful hematopoietic stem cell transplantation: unraveling the cellular components of extramedullary residual disease and donor hematopoiesis—a case report
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2023.1328503
- 995 views
Original Research
Published on 08 Jan 2024
Vhl deletion in Dmp1-expressing cells alters MEP metabolism and promotes stress erythropoiesis
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2023.1276426
- 990 views
Review
Published on 19 Dec 2023
R-loops in normal and malignant hematopoiesis
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2023.1297657
- 1,149 views
- 1 citation
Mini Review
Published on 04 Dec 2023
Bcl-2 inhibition in the treatment of hematologic malignancies
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2023.1307661
- 1,116 views
- 1 citation